Sign in

You're signed outSign in or to get full access.

Kapil Gupta

Director at Algorhythm Holdings
Board

About Kapil Gupta

Kapil Gupta (age 58) is an independent director of Algorhythm Holdings, Inc. (ticker: RIME) since October 2025. He is a global technology and business leader with 20+ years driving digital transformation; current roles include Service Line Leader for Application Operations – Public Markets (US) at IBM (since April 2025) and Project Executive for California’s Medicaid Program (since May 2017) . Earlier senior roles include Cambridge Solutions and Talisma Corporation, and Manager at KPMG LLP .

Past Roles

OrganizationRoleTenureCommittees/Impact
Cambridge SolutionsSenior leadership roles (software for supply chain, purchasing, performance)Not disclosedLed enterprise solutions scale-ups
Talisma CorporationSenior leadership roles (digital customer engagement platform)Not disclosedCustomer engagement technology leadership
KPMG LLPManagerNot disclosedAdvisory experience in audit/tax/advisory context

External Roles

OrganizationRoleTenureNotes
IBMService Line Leader, Application Operations – Public Markets (US)Since Apr 2025Global technology leadership, public markets focus
California Medicaid ProgramProject ExecutiveSince May 2017Large-scale government program execution

Board Governance

  • Independence: Gupta is classified as an independent director under Nasdaq Listing Rules .
  • Committees: Member, Audit Committee; Member, Nominating & Corporate Governance Committee .
  • Committee Chairs: Not a chair; Audit chaired by Harvey Judkowitz; Nominating chaired by Jay B. Foreman .
  • Attendance: The Board held 12 meetings in FY2024; each director serving that year attended >75% of Board and committee meetings; directors are expected to attend the annual meeting .
  • Risk oversight: Audit Committee oversees financial reporting integrity, related-party transactions, internal controls, and whistleblower processes; Compensation and Nominating committees fully independent with formal charters .

Fixed Compensation

ComponentAmountNotes
Annual cash retainer (non-employee director)$25,000Paid quarterly in advance
Committee membership retainer (per committee)$5,000Paid quarterly in advance
Expense reimbursementActualsTravel/meeting expenses reimbursed

Performance Compensation

Equity Award TypeGrant ValueVesting/TermsPerformance Metrics
Annual restricted stock award$25,000Value at issuance; vesting terms not disclosedNo director performance metrics disclosed
Annual stock option grant$25,000Value at issuance; option terms not detailed in proxyNo director performance metrics disclosed
Initial stock option (new non-employee director)$25,000One-time grant at appointment/status changeNo director performance metrics disclosed

The company maintains a clawback policy compliant with Nasdaq Rule 10D-1, applicable to Section 16 officers; director-specific clawback application is not stated .

Other Directorships & Interlocks

EntityRoleCommittee RolesNotes
None disclosedProxy does not list other public company boards for Gupta

Expertise & Qualifications

  • Deep technical expertise and strategic business acumen; experience leading large-scale operations and digital transformation in public and private sectors .
  • Government program leadership (California Medicaid) enhances public sector oversight perspective .
  • Independent status supports unbiased committee work .

Equity Ownership

HolderShares Beneficially Owned% of Outstanding Shares
Kapil Gupta0<1%

Notes: Outstanding shares at record date were 2,641,778; percent thresholds per table footnotes .

Governance Assessment

  • Board effectiveness: Gupta strengthens independence and technology/government oversight on Audit and Nominating committees; both committees are fully independent with formal charters, enhancing control environment and director selection processes .
  • Independence and conflicts: No related-party transactions involving Gupta are disclosed. Related-party transactions are overseen by the Audit Committee with recusal practices and market terms review policy, mitigating conflict risk .
  • Compensation and alignment: Non-employee director pay is balanced between cash and equity (RSUs/options at $25k each plus $25k cash), with added $5k per committee; however, Gupta held zero shares as of the record date (newly appointed), suggesting limited immediate “skin-in-the-game” but expected equity grants may improve alignment over time .
  • Attendance/engagement: Board-level data indicates a culture of engagement (>75% attendance; annual meeting attendance expected), which supports investor confidence in governance processes; Gupta’s tenure began post-FY2024 .
  • RED FLAGS: None specific to Gupta in legal proceedings or related-party dealings. Company-level dilution risk from Streeterville pre-paid financing is flagged in the proxy (price floor and potential market pressure), but this is a board-wide oversight matter rather than Gupta-specific; Audit/Nominating Committee participation is relevant to monitoring investor impact .